Immune checkpoint inhibitors in advanced non–small cell lung cancer

E-ISSN： 1097-0142|124|2|248-261

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.2, 2018-01, pp. : 248-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer

Reviews on Recent Clinical Trials, Vol. 11, Iss. 4, 2016-10 ,pp. : 297-305

Bentham Science Publishers

Access to resources Recommend Favorite

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non‐small cell lung cancer

CANCER, Vol. 120, Iss. 15, 2014-08 ,pp. : 2289-2298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer

Oncology, Vol. 91, Iss. 1, 2016-07 ,pp. : 26-34

Karger

Access to resources Recommend Favorite

Elderly Patients with Advanced Non-Small Cell Lung Cancer

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 198-203

Karger

Access to resources Recommend Favorite

Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer

Reviews on Recent Clinical Trials, Vol. 4, Iss. 2, 2009-05 ,pp. : 110-121

Bentham Science Publishers

Access to resources Recommend Favorite